TY - JOUR
T1 - Advances in Follicular-Lymphoma
AU - Archuleta, Travis D.
AU - Armitage, James O.
PY - 2004/4
Y1 - 2004/4
N2 - Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.
AB - Follicular lymphoma is a usually Indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.
UR - http://www.scopus.com/inward/record.url?scp=2342660723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342660723&partnerID=8YFLogxK
U2 - 10.1053/j.seminoncol.2004.02.007
DO - 10.1053/j.seminoncol.2004.02.007
M3 - Article
C2 - 15124137
AN - SCOPUS:2342660723
VL - 31
SP - 66
EP - 71
JO - Seminars in Oncology
JF - Seminars in Oncology
SN - 0093-7754
IS - 2 SUPPL. 4
ER -